Sfoglia per Autore
Guidance on validation and qualification of processes and operations involving radiopharmaceuticals
2017 Todde, S; Kolenc Peitl, P; Elsinga, P; Koziorowski, J; Ferrari, V; Ocak, E; Hjelstuen, O; Patt, M; Mindt, T; Behe, M
Position paper on requirements for toxicological studies in the specific case of radiopharmaceuticals
2017 Koziorowski, J; Behe, M; Decristoforo, C; Ballinger, J; Elsinga, P; Ferrari, V; Kolenc Peitl, P; Todde, S; Mindt, T
A novel versatile precursor suitable for 18F-radiolabeling via “click chemistry”
2017 Lugato, B; Stucchi, S; Ciceri, S; Iannone, M; Turolla, E; Giuliano, L; Chinello, C; Todde, S; Ferraboschi, P
European regulations for the introduction of novel radiopharmaceuticals in the clinical setting
2017 Decristoforo, C; Penuelas, I; Marianne, P; Todde, S
Divergent in vitro/in vivo responses to drug treatments of highly aggressive NIH-Ras cancer cells: A PET imaging and metabolomics-mass-spectrometry study
2016 Gaglio, D; Valtorta, S; Ripamonti, M; Bonanomi, M; Damiani, C; Todde, S; Negri, A; Sanvito, F; Mastroianni, F; Di Campli, A; Turacchio, G; Di Grigoli, G; Belloli, S; Luini, A; Gilardi, M; Colangelo, A; Alberghina, L; Moresco, R
VEGF-targeted therapy stably modulates the glycolytic phenotype of tumor cells
2015 Curtarello, M; Zulato, E; Nardo, G; Valtorta, S; Guzzo, G; Rossi, E; Esposito, G; Msaki, A; Pastò, A; Rasola, A; Persano, L; Ciccarese, F; Bertorelle, R; Todde, S; Plebani, M; Schroer, H; Walenta, S; Mueller Klieser, W; Amadori, A; Moresco, R; Indraccolo, S
EANM guideline for the preparation of an Investigational Medicinal Product Dossier (IMPD)
2014 Todde, S; Windhorst, A; Behe, M; Bormans, G; Decristoforo, C; Faivre Chauvet, A; Ferrari, V; Gee, A; Gulyas, B; Halldin, C; Kolenc Peitl, P; Koziorowski, J; Mindt, T; Sollini, M; Vercouillie, J; Ballinger, J; Elsinga, P
Guidance on current good radiopharmacypractice for the small-scale preparation of radiopharmaceuticals using automated modules: a European perspective
2014 Aerts, J; Ballinger, J; Behe, M; Decristoforo, C; Elsinga, P; Faivre Chauvet, A; Mindt, T; Kolenc Peitl, P; Todde, S; Koziorowski, J
18F-FDG PET/CT can predict nodal metastases but not recurrence in early stage uterine cervical cancer
2012 Crivellaro, C; Signorelli, M; Guerra, L; De Ponti, E; Buda, A; Dolci, C; Pirovano, C; Todde, S; Fruscio, R; Messa, M
Produzione e verifiche di qualità dei radiofarmaci estemporanei per PET e terapia
2011 Todde, S; Bogni, A; Boschi, S
Classificazione ambientale
2011 Galli, M; Todde, S
Automated production of copper radioisotopes and preparation of high specific activity [(64)Cu]Cu-ATSM for PET studies
2010 Matarrese, M; Bedeschi, P; Scardaoni, R; Sudati, F; Savi, A; Pepe, A; Masiello, V; Todde, S; Gianolli, L; Messa, M; Fazio, F
Measurements and evaluation of the risks due to external radiation exposures and to intake of activated elements for operational staff engaged in the maintenance of medical cyclotrons
2010 Calandrino, R; Del Vecchio, A; Parisi, R; Todde, S; De Felice, P; Savi, A; Pepe, A; Mrskova, A
Guidance on current good radiopharmacy practice (cGRPP) for the small-scale preparation of radiopharmaceuticals
2010 Elsinga, P; Todde, S; Penuelas, I; Meyer, G; Farstad, B; Faivre Chauvet, A; Mikolajczak, R; Westera, G; Gmeiner Stopar, T; Decristoforo, C
Intake risk and dose evaluation methods for workers in radiochemistry labs of a medical cyclotron facility
2009 Calandrino, R; Del Vecchio, A; Savi, A; Todde, S; Belloli, S
Quinolinic acid induced neurodegeneration in the striatum: a combined in vivo and in vitro analysis of receptor changes and microglia activation
2008 Moresco, R; Lavazza, T; Belloli, S; Lecchi, M; Pezzola, A; Todde, S; Matarrese, M; Carpinelli, A; Turolla, E; Zimarino, V; Popoli, P; Malgaroli, A; Fazio, F
Development of a bicistronic vector for multimodality imaging of estrogen receptor activity in a breast cancer model: preliminary application
2008 Ottobrini, L; Ciana, P; Moresco, R; Lecchi, M; Belloli, S; Martelli, C; Todde, S; Fazio, F; Gambhir, S; Maggi, A; Lucignani, G
Measurement and control of the air contamination generated in a medical cyclotron facility for PET radiopharmaceuticals
2007 Calandrino, R; del Vecchio, A; Todde, S; Fazio, F
Synthesis and carbon-11 labeling of (R)- and (S)-Thionisoxetine, norepinephrine reuptake inhibitors, potential radioligands for Positron Emission Tomography
2007 Filannino, M; Matarrese, M; Turolla, E; Masiello, V; Moresco, R; Todde, S; Verza, E; Magni, F; Cattaneo, A; Bachi, A; Kienle, M; Fazio, F
Decommissioning procedures for an 11 MeV self-shielded medical cyclotron after 16 years of working time
2006 Calandrino, R; del Vecchio, A; Savi, A; Todde, S; Griffoni, V; Brambilla, S; Parisi, R; Simone, G; Fazio, F
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile